318 related articles for article (PubMed ID: 14499735)
61. Solving the enigma: Mass spectrometry and small molecule probes to study sphingolipid function.
Millner A; Atilla-Gokcumen GE
Curr Opin Chem Biol; 2021 Dec; 65():49-56. PubMed ID: 34175552
[TBL] [Abstract][Full Text] [Related]
62. Sphingoid bases and de novo ceramide synthesis: enzymes involved, pharmacology and mechanisms of action.
Menaldino DS; Bushnev A; Sun A; Liotta DC; Symolon H; Desai K; Dillehay DL; Peng Q; Wang E; Allegood J; Trotman-Pruett S; Sullards MC; Merrill AH
Pharmacol Res; 2003 May; 47(5):373-81. PubMed ID: 12676511
[TBL] [Abstract][Full Text] [Related]
63. Roles and therapeutic targeting of ceramide metabolism in cancer.
Wajapeyee N; Beamon TC; Gupta R
Mol Metab; 2024 May; 83():101936. PubMed ID: 38599378
[TBL] [Abstract][Full Text] [Related]
64. Regulation of autophagy by sphingolipids.
Bedia C; Levade T; Codogno P
Anticancer Agents Med Chem; 2011 Nov; 11(9):844-53. PubMed ID: 21707487
[TBL] [Abstract][Full Text] [Related]
65. The sphingolipid salvage pathway in ceramide metabolism and signaling.
Kitatani K; Idkowiak-Baldys J; Hannun YA
Cell Signal; 2008 Jun; 20(6):1010-8. PubMed ID: 18191382
[TBL] [Abstract][Full Text] [Related]
66. Role of ceramide in neuronal cell death and differentiation.
Toman RE; Spiegel S; Faden AI
J Neurotrauma; 2000 Oct; 17(10):891-8. PubMed ID: 11063055
[TBL] [Abstract][Full Text] [Related]
67. Sphingolipids in mitochondria.
Hernández-Corbacho MJ; Salama MF; Canals D; Senkal CE; Obeid LM
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Jan; 1862(1):56-68. PubMed ID: 27697478
[TBL] [Abstract][Full Text] [Related]
68. Biophysics of sphingolipids I. Membrane properties of sphingosine, ceramides and other simple sphingolipids.
Goñi FM; Alonso A
Biochim Biophys Acta; 2006 Dec; 1758(12):1902-21. PubMed ID: 17070498
[TBL] [Abstract][Full Text] [Related]
69. Transcriptomics Reveal Altered Metabolic and Signaling Pathways in Podocytes Exposed to C16 Ceramide-Enriched Lipoproteins.
Hammad SM; Twal WO; Arif E; Semler AJ; Klein RL; Nihalani D
Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32045989
[TBL] [Abstract][Full Text] [Related]
70. Harnessing the power of sphingolipids: Prospects for acute myeloid leukemia.
Ung J; Tan SF; Fox TE; Shaw JJP; Vass LR; Costa-Pinheiro P; Garrett-Bakelman FE; Keng MK; Sharma A; Claxton DF; Levine RL; Tallman MS; Cabot MC; Kester M; Feith DJ; Loughran TP
Blood Rev; 2022 Sep; 55():100950. PubMed ID: 35487785
[TBL] [Abstract][Full Text] [Related]
71. Activation of a p53-independent, sphingolipid-mediated cytolytic pathway in p53-negative mouse fibroblast cells treated with N-methyl-N-nitro-N-nitrosoguanidine.
Yang J; Duerksen-Hughes PJ
J Biol Chem; 2001 Jul; 276(29):27129-35. PubMed ID: 11369765
[TBL] [Abstract][Full Text] [Related]
72. Effects of ceramide and other simple sphingolipids on membrane lateral structure.
Goñi FM; Alonso A
Biochim Biophys Acta; 2009 Jan; 1788(1):169-77. PubMed ID: 18848519
[TBL] [Abstract][Full Text] [Related]
73. Resveratrol triggers apoptosis through regulating ceramide metabolizing genes in human K562 chronic myeloid leukemia cells.
Kartal M; Saydam G; Sahin F; Baran Y
Nutr Cancer; 2011; 63(4):637-44. PubMed ID: 21500096
[TBL] [Abstract][Full Text] [Related]
74. Sphingolipid metabolism in cultured fibroblasts: microscopic and biochemical studies employing a fluorescent ceramide analogue.
Lipsky NG; Pagano RE
Proc Natl Acad Sci U S A; 1983 May; 80(9):2608-12. PubMed ID: 6573674
[TBL] [Abstract][Full Text] [Related]
75. Preferential involvement of both ROS and ceramide in fenretinide-induced apoptosis of HL60 rather than NB4 and U937 cells.
Jiang L; Pan X; Chen Y; Wang K; Du Y; Zhang J
Biochem Biophys Res Commun; 2011 Feb; 405(2):314-8. PubMed ID: 21237137
[TBL] [Abstract][Full Text] [Related]
76. The influences of sphingolipid metabolites on gentamicin-induced hair cell loss of the rat cochlea.
Nishimura B; Tabuchi K; Nakamagoe M; Hara A
Neurosci Lett; 2010 Nov; 485(1):1-5. PubMed ID: 20709153
[TBL] [Abstract][Full Text] [Related]
77. Sphingolipid metabolism and leukemia: a potential for novel therapeutic approaches.
Burns TA; Luberto C
Anticancer Agents Med Chem; 2011 Nov; 11(9):863-81. PubMed ID: 21707485
[TBL] [Abstract][Full Text] [Related]
78. Role of sphingolipids in arachidonic acid metabolism.
Nakamura H; Murayama T
J Pharmacol Sci; 2014; 124(3):307-12. PubMed ID: 24599139
[TBL] [Abstract][Full Text] [Related]
79. Ceramide in apoptotic signaling and anticancer therapy.
Lin CF; Chen CL; Lin YS
Curr Med Chem; 2006; 13(14):1609-16. PubMed ID: 16787207
[TBL] [Abstract][Full Text] [Related]
80. Clear differences in ceramide metabolism between glycosphingolipids and sphingomyelin in a human promyelocytic leukemia cell line HL-60 stimulated by a differentiation inducer.
Yokoyama K; Nojiri H; Suzuki M; Setaka M; Suzuki A; Nojima S
FEBS Lett; 1995 Jul; 368(3):477-80. PubMed ID: 7635202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
